SEC Form 4 · accession 0000921895-16-005607
Actinium Pharmaceuticals, Inc. · ATNM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Aug 26, 2016
Accepted (ET)
Aug 30, 2016 · 5:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 26, 2016 | S | 12,998 | $1.70 | D | 4,939,490 | D | |
| Common Stock | Aug 26, 2016 | S | 12,002 | $1.71 | D | 4,927,488 | D | |
| Common Stock | Aug 29, 2016 | S | 12,500 | $1.71 | D | 4,914,988 | D | |
| Common Stock | Aug 29, 2016 | S | 12,500 | $1.72 | D | 4,902,488 | D |
Table II — derivative securities
No Table II lines on this filing.